BeStock  
Stocks › Biotechnology › PGEN

Precigen PGEN

US equityMarket cap rank #2871Biotechnology
$4.21 +$0.05 (+1.20%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $4.24 +0.61%
Open$4.16
Prev close$4.16
Day range$4.07 – $4.36
Volume6.07M
Market cap$1.51B
P/E (TTM)38.3
Dividend yield–

Earnings

Average move on report day±11.9%last 16 reports
Closed higher11 of 1669% of the time
Best reaction+25.6%
Worst reaction-16.5%

Stock move on the day after each report

+17.4%2022/Q4-5.8%2023/Q1+22.6%2023/Q2+0.0%2023/Q4+5.1%2024/Q1-4.5%2024/Q2+0.6%2024/Q4+25.6%2025/Q3+25.5%2025/Q4+10.8%2026/Q1+5.5%2026/Q2-16.5%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q34 Nov 2026After Market±18.8%-16.52%Within range
2026/Q24 Aug 2026After Market±19.9%+5.51%Within range
2026/Q113 May 2026After Market±13.9%+10.84%Within range
2025/Q425 Mar 2026After Market±21.0%+25.48%Bigger than priced
2025/Q313 Nov 2025After Market±10.9%+25.65%Bigger than priced
2024/Q419 Mar 2025After Market±27.7%+0.56%Within range
2024/Q214 Aug 2024After Market±92.9%-4.46%Within range
2024/Q114 May 2024After Market±18.5%+5.11%Within range
2023/Q419 Mar 2024After Market±34.8%+0.00%Within range
2023/Q29 Aug 2023After Market±121.0%+22.58%Within range
2023/Q110 May 2023After Market±111.6%-5.79%Within range
2022/Q46 Mar 2023After Market±119.1%+17.39%Within range
2022/Q39 Nov 2022After Market±74.8%+21.09%Within range
2022/Q28 Aug 2022After Market±41.5%+12.68%Within range
2022/Q19 May 2022After Market±117.4%+12.17%Within range
2021/Q41 Mar 2022Pre Market±26.7%-4.00%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Papzimeos$72.94M 98.4%
  • Service Revenues$1.19M 1.6%
  • Exemplar$18,000.00 0.0%

Latest reported quarter: Q3, ended Sep 2026

Revenue$74.15M+2,437.6% YoY
Operating profit$38.65M+212.1% YoY
Net profit$35.77M+124.4% YoY
Diluted EPS$0.08+107.5% YoY
Free cash flow$11.45M+138.9% YoY
Operating cash flow$11.88M

Revenue, last 8 quarters

$1.2MDec '24$1.3MMar '25$856.0KJun '25$2.9MSep '25$4.6MDec '25$23.3MMar '26$55.0MJun '26$74.1MSep '26

Net profit, last 8 quarters

$-19.7MDec '24$-54.2MMar '25$-26.6MJun '25$-146.3MSep '25$-23.5MDec '25$-7.9MMar '26$20.1MJun '26$35.8MSep '26

Profitability & balance sheet

Gross margin91.4%
Operating margin21.4%
Net margin15.6%
Return on equity38.8%
Return on assets12.7%
Return on invested capital20.9%
Current ratio5.58
Liabilities / assets60.5%
Cash & investments$46.07M
Total debt$97.47M
Net cash (debt)-$51.40M

Discussion

No comments yet — be the first to weigh in on PGEN.

Sign in to join the discussion.

Scroll to Top